Woodcock: Do Not Do The Wrong Study, Even If Against US FDA Advice

 
• By Sarah Karlin-Smith
  
Janet Woodcock advises sponsors to do the right trial, even if the FDA says differently. (Shutterstock)

More from Rare Diseases

More from R&D